A disturbance in the way the body produces, uses, and distributes fat. Lipodystrophy is also referred to as "buffalo hump," or "protease paunch." In HIV disease, lipodystrophy has come to refer to a group of symptoms that seem to be related to the use of all HIV drugs. How HIV drugs may cause or trigger lipodystrophy is not yet known. Lipodystrophy symptoms involve the loss of the thin layer of fat under the skin, making veins seem to protrude; wasting of the face and limbs; and the accumulation of fat on the abdomen (both under the skin and within the abdominal cavity) or between the shoulder blades. Women may also experience narrowing of the hips and enlargement of the breasts.
the umbrella term for pronounced loss or gain of body and blood fat that mostly afflicts HIV patients and people with rare inherited disorders.
changes in body shape typically characterized by loss of fatty tissue in the limbs and face and redistribution of fat to the trunk, abdomen or back of the neck.
A disruption to the way the body produces, uses and distributes fat.
One of the most common and potentially most serious side effects of some drugs used to treat HIV/AIDS. The signs of lipodystrophy are a swollen stomach and gaunt face, arms and legs. People with lipodystrophy look like those suffering from malnutrition. These signs are associated with high levels of fats (cholesterol and triglycerides) in the blood that can cause heart disease. In some cases, lipodystrophy can lead to diabetes. Hold the tip of the condom. Squeezethe ring. Open up the vaginal lips and push the squeezed ring inside.
fat metabolism disturbance.
a metabolic syndrome characterized by glucose intolerance and changes in distribution of adipose (fat-containing) tissue.
A syndrome believed to be associated with antiretroviral therapy and generally referred to as a redistribution of body fat. Lipodystrophy may be defined as an increased amount of fat around the gut or stomach, the base of the neck and the breasts, as well as decreased fat in the legs, arms and face. Lipodystrophy is often associated with high levels of cholesterol, triglycerides, insulin or glucose in the blood.
Defective metabolism of fat. Includes fat loss, such as wasting in the face, arms, and legs, and fat redistribution, such as fat accumulation in the upper back or trunk.
a term used to describe fat redistribution, high fat levels ("lipids") in the blood, and a tendency to cause diabetes that is associated with HIV and certain treatments for HIV
A condition in which the body produces, uses, and disproportionately distributes fat. Lipodystrophy is also referred to as buffalo hump, protease paunch, or Crixivan potbelly. Lipodystrophy is thought to be related to the use of protease inhibitor and NRTI drugs, though how these drugs may cause or trigger lipodystrophy is not yet known. Lipodystrophy symptoms involve the loss of the thin layer of fat under the skin, making veins seem to protrude; wasting of the face and limbs; and the accumulation of fat on the abdomen (both under the skin and within the abdominal cavity) or between the shoulder blades.
A syndrome believed to be associated with antiretroviral therapy and generally referred to as a redistribution of body fat. Lipodystrophy may be defined as an increased amount of fat around the gut and at the base of the neck, as well as decreased fat in the legs, arms, face, and butt. Lipodystrophy is often associated with high levels of cholesterol, triglycerides, insulin, and glucose in the blood (See Hypercholesterolemia; Hypertriglyceridemia; Insulin Resistance; Hyperglycemia).
a disturbance of fat METABOLISM that involves the absence of fat and/or the abnormal distribution of fat in the body. Currently, "lipodystrophy" is not clearly defined and the term is used to refer to a variety of SYNDROMES, including wasting in the face and extremities, an accumulation of abdominal fat and breast enlargement. The cause is unknown, but it could be a result of HIV infection and/or ANTIRETROVIRAL therapy.
A disorder of adipose (fatty) tissue characterized by a selective loss of body fat . Patients with lipodystrophy have a tendency to develop insulin resistance , diabetes , a high triglyceride level (hypertriglyceridemia), and fatty liver . There are numerous forms of lipodystrophy that are genetic (inherited) or acquired (not inherited). See the entire definition of Lipodystrophy
a syndrome characterised by the redistribution of fat in the body that is probably caused by antiretroviral therapy.
loss of fatty tissue, usually in the limbs and face. The term is also sometimes used to refer to any type of body fat redistribution.
A disturbance in the way the body produces, uses, and distributes fat. Lipodystrophy is also referred to as buffalo hump, protease paunch, or Crixivan potbelly. In HIV disease, lipodystrophy has come to refer to a group of symptoms that seem to be related to the use of protease inhibitor and NRTI drugs.
Any disturbance in the normal distribution or metabolism of fat throughout the body. May be associated with the use of antiviral therapy including protease inhibitors. Fat deposits tend to be located on the stomach or upper back. The related term 'lipoatrophy' refers to the loss of body fat from the face and extremities (legs and arms).
Lipodystrophy is a medical condition characterized by abnormal or degenerative conditions of the body's adipose tissue. ("Lipo" is Latin for "fat" and "dystrophy" is Latin for "abnormal or degenerative condition".) A more specific term, lipoatrophy is used when describing the loss of fat from one area (usually the face).